Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Vagus Nerve Preservation and Chronic Cough in Non-small Cell Lung Cancer Surgery

24. října 2022 aktualizováno: Kwhanmien Kim, Seoul National University Bundang Hospital

Prospective Randomized Controlled Study on the Effects of Vagus Nerve Pulmonary Branch Preservation During Video-assisted Thoracic Surgery Lobectomy in Non-small Cell Lung Cancer: Can it Decrease Postoperative Cough and Pulmonary Complications

Lung cancer is the leading cause of cancer death worldwide. Surgical resection is the main treatment for resectable non-small-cell lung cancer (NSCLC), and lobectomy with systemic mediastinal lymph node dissection is the standard surgical method. However, a significant number of patients experience postoperative chronic cough; it is observed in about 60% of patients during the first year of outpatient clinic follow-up, and persistently lasts in about 24.7-50% during the 5 year follow-up period.

Several studies showed the association between vagus nerve and chronic cough. The bronchopulmonary vagal afferent C-fibers are responsible for cough, chest tightness and reflex bronchoconstrictions. It is expected that during the mediastinal lymph node dissection, the inevitable injuries to the pulmonary branch of vagus nerve is largely responsible for development of chronic cough. In other words, preservation of pulmonary branch of vagus nerve may reduce the incidence of chronic cough and relevant detrimental effects on quality of life.

Therefore, this prospective, randomized and controlled clinical study, aims to evaluate the effect of vagus nerve preservation on postoperative chronic cough in patients undergoing lobectomy with mediastinal lymph node dissection. In addition, the feasibility and oncologic safety of preserving pulmonary branch of vagus nerve during mediastinal lymph node dissection with minimally invasive surgery compared with conventional mediastinal lymph node dissection with minimally invasive surgery will also be investigated.

This trial will provide a new basis for oncologically feasible, safe and effective new surgical technique for mediastinal lymph node dissection in patients with early lung cancer undergoing minimally invasive surgery. Furthermore, the preventive effect of vagus nerve preservation on incidence of chronic cough will be objectively be proven and thus help to broaden the current knowledge of the role of vagus nerve and postoperative chronic cough.

Přehled studie

Typ studie

Intervenční

Zápis (Očekávaný)

214

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

  • Jméno: Kwhanmien Kim, MD. PhD
  • Telefonní číslo: +82-31-787-7130
  • E-mail: kmkim0070@snubh.org

Studijní místa

    • Bundang
      • Seongnam-si, Bundang, Korejská republika, 13620
        • Nábor
        • Seoul National University
        • Kontakt:
          • Beatrice C Shih, MD
          • Telefonní číslo: 821091094533
          • E-mail: 82430@snubh.org
        • Vrchní vyšetřovatel:
          • Kwhanmien Kim, MD.PhD.

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let až 80 let (Dospělý, Starší dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  1. Subjects clearly understand the purpose of the study, are willing and able to comply with the requirements to complete the study, and can sign the informed consent.
  2. Clinically suspicious of non-small cell lung cancer or tissue confirmed preoperatively
  3. Clinical stage T1-3/N0-1/M0
  4. Preoperative ECOG performance status 0-1
  5. Preoperative ASA class I-III
  6. Preoperative pulmonary function test FEV1 ≥ 60%, DLCO ≥ 60%
  7. Patients expected to achieve R0 (complete resection) via simple lobectomy and mediastinal lymph node dissection

Exclusion Criteria:

  1. Patients who smoked within 2 weeks prior to operation
  2. Patients who received antitussives and expectorants 2 weeks prior to operation
  3. Patients who are pregnant or breast feeding
  4. Patients with severe or uncontrolled psychological disorders
  5. Patients with severe pulmonary adhesion
  6. Patients who are ineligible for minimally invasive surgery; thoracotomy conversion
  7. Patients diagnosed with other malignancies within 2 years prior to operation
  8. Patients who received chemotherapy or radiotherapy within 6 months prior to operation
  9. Patients suspicious of clinical N2 or received neoadjuvant therapy prior to operation
  10. Patients with cough-related diseases; COPD, asthma, ILD, GERD
  11. Patients suspicious of lymph node metastasis/invasion around vagus nerve during the preoperative clinical staging evaluation

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Léčba
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Žádné (otevřený štítek)

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: Pulmonary branch of vagus nerve preserved
Pulmonary branch of vagus nerve is preserved during the mediastinal lymph node dissection using minimally invasive surgery
During the mediastinal lymph node dissection using minimally invasive surgery, efforts to preserve the pulmonary branch of vagus nerve is made.
Experimentální: Pulmonary branch of vagus nerve not-preserved
Pulmonary branch of vagus nerve is not preserved during the mediastinal lymph node dissection using minimally invasive surgery
During the mediastinal lymph node dissection using minimally invasive surgery, efforts to preserve the pulmonary branch of vagus nerve is not made/ can be severed.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Qualitative measurement of postoperative cough
Časové okno: Preoperative day
Cough Visual Analog Scale (VAS) will be used for survey. The Cough VAS is a numeric scale from 0-10 scale, with 0 indicating that patient experiences no distress from cough and 10 indicating severe distress from cough.
Preoperative day
Qualitative measurement of postoperative cough
Časové okno: Postoperative day (discharge day, an average of 1 week)
Cough Visual Analog Scale (VAS) will be used for survey. The Cough VAS is a numeric scale from 0-10 scale, with 0 indicating that patient experiences no distress from cough and 10 indicating severe distress from cough.
Postoperative day (discharge day, an average of 1 week)
Qualitative measurement of postoperative cough
Časové okno: Postoperative 1 month follow up at outpatient clinic
Cough Visual Analog Scale (VAS) will be used for survey. The Cough VAS is a numeric scale from 0-10 scale, with 0 indicating that patient experiences no distress from cough and 10 indicating severe distress from cough.
Postoperative 1 month follow up at outpatient clinic
Qualitative measurement of postoperative cough
Časové okno: Postoperative 2 month follow up at outpatient clinic
Cough Visual Analog Scale (VAS) will be used for survey. The Cough VAS is a numeric scale from 0-10 scale, with 0 indicating that patient experiences no distress from cough and 10 indicating severe distress from cough.
Postoperative 2 month follow up at outpatient clinic
Qualitative measurement of postoperative cough
Časové okno: Postoperative 6 month follow up at outpatient clinic
Cough Visual Analog Scale (VAS) will be used for survey. The Cough VAS is a numeric scale from 0-10 scale, with 0 indicating that patient experiences no distress from cough and 10 indicating severe distress from cough.
Postoperative 6 month follow up at outpatient clinic
Qualitative measurement of postoperative cough
Časové okno: Postoperative 12 month follow up at outpatient clinic
Cough Visual Analog Scale (VAS) will be used for survey. The Cough VAS is a numeric scale from 0-10 scale, with 0 indicating that patient experiences no distress from cough and 10 indicating severe distress from cough.
Postoperative 12 month follow up at outpatient clinic
Quantitative measurement of postoperative cough
Časové okno: Preoperative day
The Korean version of the Leicester Cough Questionnaire will be used for survey. Comparison of preoperative and and postoperative change in objective cough frequency and quality of life among patients using the Leicester Cough Questionnaire, which is a 7 point Likert scale with a minimum value of 1 indicating chronic cough impacts participant life all of the time and a maximum value of 7 indicating chronic cough impacts participant life none of the time.
Preoperative day
Quantitative measurement of postoperative cough
Časové okno: Postoperative day (discharge day, an average of 1 week)
The Korean version of the Leicester Cough Questionnaire will be used for survey. Comparison of preoperative and and postoperative change in objective cough frequency and quality of life among patients using the Leicester Cough Questionnaire, which is a 7 point Likert scale with a minimum value of 1 indicating chronic cough impacts participant life all of the time and a maximum value of 7 indicating chronic cough impacts participant life none of the time.
Postoperative day (discharge day, an average of 1 week)
Quantitative measurement of postoperative cough
Časové okno: Postoperative 1 month follow up at outpatient clinic
The Korean version of the Leicester Cough Questionnaire will be used for survey. Comparison of preoperative and and postoperative change in objective cough frequency and quality of life among patients using the Leicester Cough Questionnaire, which is a 7 point Likert scale with a minimum value of 1 indicating chronic cough impacts participant life all of the time and a maximum value of 7 indicating chronic cough impacts participant life none of the time.
Postoperative 1 month follow up at outpatient clinic
Quantitative measurement of postoperative cough
Časové okno: Postoperative 2 month follow up at outpatient clinic
The Korean version of the Leicester Cough Questionnaire will be used for survey. Comparison of preoperative and and postoperative change in objective cough frequency and quality of life among patients using the Leicester Cough Questionnaire, which is a 7 point Likert scale with a minimum value of 1 indicating chronic cough impacts participant life all of the time and a maximum value of 7 indicating chronic cough impacts participant life none of the time.
Postoperative 2 month follow up at outpatient clinic
Quantitative measurement of postoperative cough
Časové okno: Postoperative 6 month follow up at outpatient clinic
The Korean version of the Leicester Cough Questionnaire will be used for survey. Comparison of preoperative and and postoperative change in objective cough frequency and quality of life among patients using the Leicester Cough Questionnaire, which is a 7 point Likert scale with a minimum value of 1 indicating chronic cough impacts participant life all of the time and a maximum value of 7 indicating chronic cough impacts participant life none of the time.
Postoperative 6 month follow up at outpatient clinic
Quantitative measurement of postoperative cough
Časové okno: Postoperative 12 month follow up at outpatient clinic
The Korean version of the Leicester Cough Questionnaire will be used for survey. Comparison of preoperative and and postoperative change in objective cough frequency and quality of life among patients using the Leicester Cough Questionnaire, which is a 7 point Likert scale with a minimum value of 1 indicating chronic cough impacts participant life all of the time and a maximum value of 7 indicating chronic cough impacts participant life none of the time.
Postoperative 12 month follow up at outpatient clinic

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Serum TRPA1, TRPV1, bradykinin, PGE2 measurements
Časové okno: Preoperative day
Measurement of TRPA1 (ng/mL), TRPV1 (ng/mL), bradykinin (pg/mL), PGE2 (pg/mL) (released from C-fibers) via enzyme-linked immunosorbent assay (ELISA) test to quantitatively measure the injures of the vagus nerve during the mediastinal lymph node dissection.
Preoperative day
Serum TRPA1, TRPV1, bradykinin, PGE2 measurements
Časové okno: Postoperative 1 day
Measurement of TRPA1 (ng/mL), TRPV1 (ng/mL), bradykinin (pg/mL), PGE2 (pg/mL) (released from C-fibers) via enzyme-linked immunosorbent assay (ELISA) test to quantitatively measure the injures of the vagus nerve during the mediastinal lymph node dissection.
Postoperative 1 day
Serum TRPA1, TRPV1, bradykinin, PGE2 measurements
Časové okno: Postoperative 2 month follow up at outpatient clinic
Measurement of TRPA1 (ng/mL), TRPV1 (ng/mL), bradykinin (pg/mL), PGE2 (pg/mL) (released from C-fibers) via enzyme-linked immunosorbent assay (ELISA) test to quantitatively measure the injures of the vagus nerve during the mediastinal lymph node dissection.
Postoperative 2 month follow up at outpatient clinic
Pulmonary function test
Časové okno: Preoperative day
Routine PFT (FEV1%, FEV1/FVC%) check to evaluate the effects of vagus nerve preservation in pulmonary function
Preoperative day
Pulmonary function test
Časové okno: Postoperative 1 month follow up at outpatient clinic
Routine PFT (FEV1%, FEV1/FVC%) check to evaluate the effects of vagus nerve preservation in pulmonary function
Postoperative 1 month follow up at outpatient clinic
Pulmonary function test
Časové okno: Postoperative 2 month follow up at outpatient clinic
Routine PFT (FEV1%, FEV1/FVC%) check to evaluate the effects of vagus nerve preservation in pulmonary function
Postoperative 2 month follow up at outpatient clinic
Pulmonary function test
Časové okno: Postoperative 6 month follow up at outpatient clinic
Routine PFT (FEV1%, FEV1/FVC%) check to evaluate the effects of vagus nerve preservation in pulmonary function
Postoperative 6 month follow up at outpatient clinic
Pulmonary function test
Časové okno: Postoperative 12 month follow up at outpatient clinic
Routine PFT (FEV1%, FEV1/FVC%) check to evaluate the effects of vagus nerve preservation in pulmonary function
Postoperative 12 month follow up at outpatient clinic
Incidence of postoperative pulmonary complications, hospital stay and readmission, ICU care
Časové okno: from admission for operation to until the date of first documented postoperative complication or readmission, whichever came first), assessed up to 30 days
from admission for operation to until the date of first documented postoperative complication or readmission, whichever came first), assessed up to 30 days
Histopathologic review of the total number of mediastinal lymph node dissected
Časové okno: through study completion, an average of 1 year
Total number of dissected mediastinal lymph nodes and metastatic lymph nodes will be analyzed. Patient's preoperative clinical N stage and pathologic N stage will be compared; if pathologic N stage is higher than that of the clinical N stage, it will be considered as nodal upstaging.
through study completion, an average of 1 year

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Ředitel studie: Kwhanmien Kim, MD. PhD, Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

1. července 2021

Primární dokončení (Očekávaný)

30. června 2023

Dokončení studie (Očekávaný)

30. června 2023

Termíny zápisu do studia

První předloženo

23. května 2021

První předloženo, které splnilo kritéria kontroly kvality

6. června 2021

První zveřejněno (Aktuální)

11. června 2021

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

26. října 2022

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

24. října 2022

Naposledy ověřeno

1. října 2022

Více informací

Termíny související s touto studií

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit